David Hardick

1.2k total citations
19 papers, 823 citations indexed

About

David Hardick is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, David Hardick has authored 19 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Organic Chemistry. Recurrent topics in David Hardick's work include Plant-based Medicinal Research (8 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Alkaloids: synthesis and pharmacology (3 papers). David Hardick is often cited by papers focused on Plant-based Medicinal Research (8 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Alkaloids: synthesis and pharmacology (3 papers). David Hardick collaborates with scholars based in United Kingdom and New Zealand. David Hardick's co-authors include Barry V. L. Potter, Ian S. Blagbrough, Susan Wonnacott, Adrian J. Wolstenholme, Andrew R. Davies, D. W. Hutchinson, Elizabeth M. H. Wellington, Gary R. Cooper, John Milton and Nigel Vicker and has published in prestigious journals such as Journal of the American Chemical Society, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

David Hardick

19 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hardick United Kingdom 16 546 331 197 157 74 19 823
Nuria Cabedo Spain 20 477 0.9× 490 1.5× 84 0.4× 209 1.3× 60 0.8× 67 1.2k
Jörg Holenz Germany 24 615 1.1× 830 2.5× 155 0.8× 154 1.0× 249 3.4× 43 1.4k
Sean P. Hollinshead United States 16 417 0.8× 483 1.5× 95 0.5× 155 1.0× 82 1.1× 33 761
Ga Young Lee South Korea 16 402 0.7× 355 1.1× 73 0.4× 73 0.5× 117 1.6× 36 1.2k
Alexander Kasal Czechia 15 444 0.8× 201 0.6× 93 0.5× 59 0.4× 106 1.4× 118 807
Kimiko Hashimoto Japan 23 548 1.0× 747 2.3× 56 0.3× 360 2.3× 96 1.3× 70 1.4k
Csaba Szántay Hungary 15 262 0.5× 579 1.7× 225 1.1× 88 0.6× 37 0.5× 86 880
Zoltán Béni Hungary 15 214 0.4× 199 0.6× 72 0.4× 123 0.8× 46 0.6× 54 614
Gábor Blaskó Hungary 21 473 0.9× 739 2.2× 191 1.0× 200 1.3× 41 0.6× 75 1.3k
Miwa Kubo Japan 25 870 1.6× 582 1.8× 289 1.5× 237 1.5× 78 1.1× 100 1.7k

Countries citing papers authored by David Hardick

Since Specialization
Citations

This map shows the geographic impact of David Hardick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hardick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hardick more than expected).

Fields of papers citing papers by David Hardick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hardick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hardick. The network helps show where David Hardick may publish in the future.

Co-authorship network of co-authors of David Hardick

This figure shows the co-authorship network connecting the top 25 collaborators of David Hardick. A scholar is included among the top collaborators of David Hardick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hardick. David Hardick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pollack, Scott J., Kim S. Beyer, Christopher Lock, et al.. (2011). A comparative study of fragment screening methods on the p38α kinase: new methods, new insights. Journal of Computer-Aided Molecular Design. 25(7). 677–687. 26 indexed citations
2.
Gibson, Susan E., David Hardick, Peter Haycock, et al.. (2007). A Study of (Binap)(enyne)tetracarbonyldicobalt(0) Complexes. Chemistry - A European Journal. 13(25). 7099–7109. 9 indexed citations
3.
Gibson, Susan E., et al.. (2007). Pendant Alkenes Promote Cobalt−Cobalt Bond Cleavage in (Alkyne)(binap)tetracarbonyldicobalt(0) Complexes. Organometallics. 26(7). 1578–1580. 21 indexed citations
4.
Wang, Shouming, Warren Miller, John Milton, et al.. (2002). Structure–activity relationships for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576. Bioorganic & Medicinal Chemistry Letters. 12(3). 415–418. 49 indexed citations
5.
Vicker, Nigel, Irina Chuckowree, Adrian Folkes, et al.. (2002). Novel Angular Benzophenazines:  Dual Topoisomerase I and Topoisomerase II Inhibitors as Potential Anticancer Agents. Journal of Medicinal Chemistry. 45(3). 721–739. 116 indexed citations
6.
Lind, Robert J., David Hardick, Ian S. Blagbrough, et al.. (2001). [3H]-Methyllycaconitine: a high affinity radioligand that labels invertebrate nicotinic acetylcholine receptors. Insect Biochemistry and Molecular Biology. 31(6-7). 533–542. 21 indexed citations
7.
Wrigley, Stephen K., A. Martyn Ainsworth, Steven M. Martin, et al.. (2001). Novel Reduced Benzo[j]fluoranthen-3-ones from Cladosporium cf. cladosporioides with Cytokine Production and Tyrosine Kinase Inhibitory Properties.. The Journal of Antibiotics. 54(6). 479–488. 14 indexed citations
8.
Davies, Andrew R., David Hardick, Ian S. Blagbrough, et al.. (1999). Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology. 38(5). 679–690. 222 indexed citations
9.
Davies, Andrew R., David Hardick, Ian S. Blagbrough, et al.. (1997). Structure-activity studies of bicyclic and tricyclic analogues of methyllycaconitine. Biochemical Society Transactions. 25(3). 545S–545S. 17 indexed citations
10.
Hardick, David, Ian S. Blagbrough, & Barry V. L. Potter. (1996). Isotopic Enrichment by Asymmetric Deuteriation. An Investigation of the Synthesis of Deuteriated (S)-(−)-Methylsuccinic Acids from Itaconic Acid. Journal of the American Chemical Society. 118(25). 5897–5903. 26 indexed citations
12.
Hardick, David, Gary R. Cooper, Toby S. Scott‐Ward, et al.. (1995). Conversion of the sodium channel activator aconitine into a potent α7‐selective nicotinic ligand. FEBS Letters. 365(1). 79–82. 32 indexed citations
13.
Hardick, David, Ian S. Blagbrough, Susan Wonnacott, & Barry V. L. Potter. (1994). Regioselective anthranoylation of demethylated aconitine: Novel analogues of aconitine inuline and methyllycaconitine. Tetrahedron Letters. 35(20). 3371–3374. 25 indexed citations
14.
Blagbrough, Ian S., David Hardick, Terence Lewis, et al.. (1994). Acylation of lycoctonine: Semi-synthesis of inuline, delsemine analogues and methyllycaconitine. Tetrahedron Letters. 35(46). 8705–8708. 29 indexed citations
15.
Hardick, David & D. W. Hutchinson. (1994). An improved, practical synthesis of 5-[2H]-D-glucose. Bioorganic & Medicinal Chemistry Letters. 4(3). 409–414. 5 indexed citations
16.
Blagbrough, Ian S., David Hardick, Susan Wonnacott, & Barry V. L. Potter. (1994). Regioselective demethylation of aconitine. Tetrahedron Letters. 35(20). 3367–3370. 15 indexed citations
18.
Hardick, David, et al.. (1992). Glucose is a Precursor of 1-deoxynojirimycin and 1-deoxymannonojirimycin in Streptomyces subrutilus. Tetrahedron. 48(30). 6285–6296. 69 indexed citations
19.
Hardick, David, et al.. (1991). The biosynthesis of deoxynojirimycin and deoxymannonojirimycin in Streptomyces subrutilus. Journal of the Chemical Society Chemical Communications. 729–729. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026